Continuous Adductor Canal Block for Total Knee Arthroplasty Analgesia

NCT ID: NCT02387021

Last Updated: 2015-03-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-03-31

Study Completion Date

2015-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the study is to determine whether the association of sciatic nerve block to continuous adductor canal block is effective in the treatment of total knee arthroplasty post operative pain .

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Neuromuscular Blockade Pain Management

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Continous femoral nerve block

Patients will receive ultrasound-guided (USG) continuous femoral nerve block with 20 ml ropivacaine 0.2% and USG Continuous adductor canal block with 20 ml of saline and USG infragluteal SNB with 20 ml of saline .

Group Type ACTIVE_COMPARATOR

Continuous femoral nerve block

Intervention Type PROCEDURE

Continuous adductor canal block

Intervention Type PROCEDURE

infragluteal Sciatic nerve block

Intervention Type PROCEDURE

Ropivacaine 0.2%

Intervention Type DRUG

Saline

Intervention Type DRUG

Continuous adductor canal block

Patients will receive ultrasound-guided continuous adductor canal block with 20 ml ropivacaine 0.2% and USG infragluteal SNB with 20 ml ropivacaine 0.2% and USG continuous FNB with 20 ml of saline .

Group Type EXPERIMENTAL

Continuous femoral nerve block

Intervention Type PROCEDURE

Continuous adductor canal block

Intervention Type PROCEDURE

infragluteal Sciatic nerve block

Intervention Type PROCEDURE

Ropivacaine 0.2%

Intervention Type DRUG

Saline

Intervention Type DRUG

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Continuous femoral nerve block

Intervention Type PROCEDURE

Continuous adductor canal block

Intervention Type PROCEDURE

infragluteal Sciatic nerve block

Intervention Type PROCEDURE

Ropivacaine 0.2%

Intervention Type DRUG

Saline

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Elective unilateral TKA,
* Planned continuous spinal anesthesia ,
* Ability to follow study protocol,
* American Society of Anesthesiologists class 1 to 3.

Exclusion Criteria

* Contraindication for neuraxial anesthetic,
* Chronic opioid use (defined as daily or almost daily use of opioids for \>3 months),
* Hypersensitivity and/or allergies to any of the study medications,
* Intraoperative use of volatile anesthetics,
* Preexisting neuropathy on the operative limb,
* Contraindications to a femoral, adductor canal or Tibial nerve block.
Minimum Eligible Age

18 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Institut Kassab d'Orthopédie

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Rais Karim

Dr

Responsibility Role PRINCIPAL_INVESTIGATOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Karim Raies, M.D

Role: CONTACT

+21655208602

References

Explore related publications, articles, or registry entries linked to this study.

Kim DH, Lin Y, Goytizolo EA, Kahn RL, Maalouf DB, Manohar A, Patt ML, Goon AK, Lee YY, Ma Y, Yadeau JT. Adductor canal block versus femoral nerve block for total knee arthroplasty: a prospective, randomized, controlled trial. Anesthesiology. 2014 Mar;120(3):540-50. doi: 10.1097/ALN.0000000000000119.

Reference Type BACKGROUND
PMID: 24401769 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

P-2015002/AR

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Adductor Canal Block
NCT04513145 ACTIVE_NOT_RECRUITING PHASE2/PHASE3
High Versus Low Adductor Canal Block
NCT04155983 UNKNOWN PHASE4